Critique on the use of early short-term dual antiplatelet therapy following minor acute cerebral ischemic events

M Moussouttas, NIH Papamitsakis - Cerebrovascular Diseases, 2020 - karger.com
Background: Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients
with Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented …
被引用次数：8 相关文章
[PDF] academia.edu

[PDF][PDF] Critique on the Use of Early Short-Term Dual Antiplatelet Therapy Following Minor Acute Cerebral Ischemic Events

MMNIH Papamitsakisb - Cerebrovasc Dis, 2020 - academia.edu
Background: Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients
with Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented …

Critique on the Use of Early Short-Term Dual Antiplatelet Therapy Following Minor Acute Cerebral Ischemic Events.

M Moussouttas, NIH Papamitsakis - Cerebrovascular Diseases, 2020 - go.gale.com
Background: Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients
with Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented …

Critique on the Use of Early Short-Term Dual Antiplatelet Therapy Following Minor Acute Cerebral Ischemic Events

M Moussouttas… - Cerebrovascular …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients with
Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in …

Critique on the Use of Early Short-Term Dual Antiplatelet Therapy Following Minor Acute Cerebral Ischemic Events

M Moussouttas, NIH Papamitsakis - Cerebrovascular Diseases, 2020 - karger.com
Background: Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients
with Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented …
[PDF] archive.org

[PDF][PDF] Critique on the Use of Early Short-Term Dual Antiplatelet Therapy Following Minor Acute Cerebral Ischemic Events

MMNIH Papamitsakisb - Cerebrovasc Dis, 2020 - scholar.archive.org
Background: Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients
with Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented …

Critique on the Use of Early Short-Term Dual Antiplatelet Therapy Following Minor Acute Cerebral Ischemic Events.

M Moussouttas, NIH Papamitsakis - … Diseases (Basel, Switzerland), 2020 - europepmc.org
BACKGROUND: Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients
with Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented …

Critique on the Use of Early Short-Term Dual Antiplatelet Therapy Following Minor Acute Cerebral Ischemic Events.

M Moussouttas… - Cerebrovascular …, 2020 - search.ebscohost.com
Background: Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients
with Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented …